Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate in primary obsessive-compulsive disorder.

R T Joffe1, R P Swinson

  • 1Department of Psychiatry, St. Michael's Hospital, Toronto, Ontario, Canada.

Journal of Clinical Psychopharmacology
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pharmacological management of depression.

Canadian family physician Medecin de famille canadien·2011
Same author

Cognitive features of social phobia.

CNS spectrums·2008
Same author

One-year outcome with antidepressant--treatment of bipolar depression.

Acta psychiatrica Scandinavica·2005
Same author

Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial.

The Journal of clinical endocrinology and metabolism·2003
Same author

Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant.

Acta psychiatrica Scandinavica·2002
Same author

Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status.

Psychological medicine·2002

Methylphenidate did not significantly impact obsessive-compulsive disorder (OCD) symptoms overall. However, some patients showed reduced obsessive-compulsive behaviors or improved mood, suggesting potential individual responses to this stimulant medication.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Obsessive-compulsive disorder (OCD) is a debilitating psychiatric condition.
  • Methylphenidate, a central nervous system stimulant, is primarily used for ADHD.
  • The efficacy of methylphenidate in OCD is not well-established.

Purpose of the Study:

  • To investigate the acute effects of methylphenidate on patients with primary OCD.
  • To assess methylphenidate's impact on mood and obsessive-compulsive behaviors.

Main Methods:

  • An acute challenge study involving methylphenidate administration.
  • Involved 13 patients diagnosed with primary obsessive-compulsive disorder.
  • Behavioral and mood scales were used to measure outcomes.

Related Experiment Videos

Main Results:

  • No significant overall effect of methylphenidate on mood or OCD symptoms was observed.
  • Four out of 13 patients exhibited an antiobsessive-compulsive response.
  • One patient demonstrated an antidepressant response to methylphenidate.

Conclusions:

  • Methylphenidate does not appear to be effective for OCD as a whole.
  • Individual variability in response suggests potential for specific patient subgroups.
  • Further research is warranted to explore these differential responses.